Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BMY will rise by +2.35% over the next 2 Weeks and hit $67.01 by Thursday, September 3, 2026. In that time frame, BMY's share price is expected to range between $65.89 and $68.26.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 3, 2026 | 65.89 | 67.01 | 68.26 |
| Sep 2, 2026 | 65.22 | 66.40 | 67.52 |
| Sep 1, 2026 | 65.67 | 66.81 | 67.91 |
| Aug 31, 2026 | 65.71 | 66.77 | 67.87 |
| Aug 28, 2026 | 65.80 | 66.89 | 68.00 |
| Aug 27, 2026 | 65.86 | 66.93 | 67.95 |
| Aug 26, 2026 | 65.28 | 66.31 | 67.37 |
| Aug 25, 2026 | 65.67 | 66.73 | 67.79 |
| Aug 24, 2026 | 65.71 | 66.69 | 67.76 |
| Aug 21, 2026 | 65.71 | 66.81 | 67.83 |
BMY shares rose +2.35% in Friday, August 21, 2026's trading session, rising from a previous close of $65.47 to move at $67.01. The stock demonstrated notable intraday movement (see BMY's key stats for a full breakdown), fluctuating between $65.13 and $67.55, a +3.72% trading range. While recent weeks have seen some volatility, BMY has managed to secure a +3.35% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 6.83M shares changing hands, 2.6M fewer than the previous session. This amounted to $457.44M in total market activity.
Will BMY Continue Its Upward Trend?
According to analyst ratings and projections for BMY, Bristol-Myers Squibb Company shares are anticipated to increase by +1.83%, potentially reaching $68.26 per share by September 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for BMY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 22 positive trading days within the past 30 sessions. Based on the BMY stock forecast, now is a good time to buy BMY stock because its current trading price is 0 our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on BMY covering social and institutional perspectives.
BMY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BMY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 61.85% to 63.02%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 58.16%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.93%, maintains a neutral outlook for the long term. Insights into BMY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Bristol-Myers Squibb Short-Term Forecasts
BMY Forecast For Next 5 Days
Our algorithm anticipates Bristol-Myers Squibb (BMY) stock could hit $68.52 by Aug 28, 2026. This represents a +2.25% fall from today's price, following a -2.78% change over the past five days.
BMY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Bristol-Myers Squibb Company (BMY) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $67.73, which would mean a +1.07% increase from the current price of $67.01. Projections for this period range from a high of $70.18 to a low of $65.45.
BMY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Bristol-Myers Squibb's price over the next three months point to a rise. BMY stock is expected to peak at $72.09 on Nov 11, 2026 after potentially dipping to $62.67 on Oct 12, 2026. On average, BMY is likely to trade around $67.44 in the coming 90 days.
Bristol-Myers Squibb Stock Forecast 2025
Based on our predictive models, Bristol-Myers Squibb (BMY) is expected to trade between $62.67 and $72.09 throughout 2026. This would result in an average price of $67.47, potentially offering investors a +0.69% return from current levels.
Bristol-Myers Squibb Company Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Bristol-Myers Squibb Company (BMY) is positioned to show a strong performance in August 2026. The price is predicted to move between $63.29 and $69.38, settling at an average of $66.39. This could translate to a -0.93% loss.
September 2026
Based on current market signals, Bristol-Myers Squibb Company is projected to trend september 2026. We forecast a trading range from $64.15 to $71.85, with a likely average price of $67.61. Investors could expect a potential return of +0.90%.
October 2026
Our predictive algorithms indicate Bristol-Myers Squibb Company stock may see a shift in October 2026. The expected range spans $62.67–$70.59, with an average target of $67.27. This represents a positive outlook and a possible gain of +0.39%.
November 2026
Analyzing established trends, Bristol-Myers Squibb Company looks set to move in November 2026. Projections place the stock between $64.65 and $72.09, averaging around $67.83. This suggests a +1.22% gain from current levels.
December 2026
Market indicators suggest Bristol-Myers Squibb Company could experience notable changes during December 2026. Prices could fluctuate within $64.29 to $71.10, with a midpoint forecast of $67.51. The stock might deliver a +0.75% gain.
January 2027
Forecasting for January 2027, models estimate that Bristol-Myers Squibb Company may undergo key fluctuations. If trends hold, the stock might trade between $63.40 and $70.36, averaging $66.91. This signals a cautious trajectory with potential returns around -0.15%.
February 2027
According to our latest forecast models, Bristol-Myers Squibb Company (BMY) is positioned to show a strong performance in February 2027. The price is predicted to move between $64.27 and $71.26, settling at an average of $67.73. This could translate to a +1.07% gain.
March 2027
Based on current market signals, Bristol-Myers Squibb Company is projected to trend march 2027. We forecast a trading range from $64.23 to $70.56, with a likely average price of $67.41. Investors could expect a potential return of +0.60%.
April 2027
Our predictive algorithms indicate Bristol-Myers Squibb Company stock may see a shift in April 2027. The expected range spans $64.79–$71.66, with an average target of $67.77. This represents a positive outlook and a possible gain of +1.13%.
May 2027
Analyzing established trends, Bristol-Myers Squibb Company looks set to move in May 2027. Projections place the stock between $63.91 and $70.66, averaging around $67.57. This suggests a +0.84% gain from current levels.
June 2027
Market indicators suggest Bristol-Myers Squibb Company could experience notable changes during June 2027. Prices could fluctuate within $63.53 to $70.77, with a midpoint forecast of $66.95. The stock might deliver a -0.09% loss.
July 2027
Forecasting for July 2027, models estimate that Bristol-Myers Squibb Company may undergo key fluctuations. If trends hold, the stock might trade between $64.08 and $71.28, averaging $67.72. This signals a positive trajectory with potential returns around +1.06%.
August 2027
According to our latest forecast models, Bristol-Myers Squibb Company (BMY) is positioned to show a strong performance in August 2027. The price is predicted to move between $64.38 and $70.72, settling at an average of $67.42. This could translate to a +0.61% gain.
BMY's history of dividends and stock splits also plays a role in long-term investor confidence.